Abstract
Simultaneous Global Phase I Studies of a Differentiated BTK Inhibitor, Dtrmwxhs-12, in Relapsed/Refractory Patients with Chronic Lymphocytic Leukemia and B-Cell Lymphomas
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have